Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Providing essential cancer care to rural communities
2.
CAR T cells improve patients' quality of life: a study
3.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
4.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
5.
Severe obesity associated with reduced prevalence of recommended cancer screenings
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings
3.
Know About Lymphangioma: Symptoms, Causes, and Treatments
4.
Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life
5.
Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation